"FDA Mandates Ozempic to Include Lethal Side Effect on Label"

The FDA is updating the warning label for the diabetes and weight-loss drug Ozempic to include a potentially deadly side effect: intestinal blockage. The medication can cause a condition called ileus, where parts or all of the intestines become blocked, leading to tissue death and a risk of gastric juices leaking into the body. This complication, which has a fatality rate of up to one in ten, will be added to the already listed side effects of nausea, vomiting, diarrhea, and constipation. The FDA has received 33 reports of this condition out of 19,000 adverse reactions recorded, and Novo Nordisk, the manufacturer of Ozempic, maintains that the drug is safe and effective when used as directed.